Enovis Announces Fourth Quarter and Full Year 2023 Results
February 22, 2024 06:00 ET
|
Enovis Corporation
Continued strong momentum with fourth-quarter sales growth of 11%, organic growth of 8% Reported fourth-quarter net income from continuing operations of $0.05 per share with adjusted earnings per...
Enovis™ to Highlight Latest Technologies Across the Orthopedic Care Continuum at 2024 AAOS Annual Meeting
February 12, 2024 11:30 ET
|
Enovis Corporation
WILMINGTON, DE, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology company, will showcase its latest technologies across the orthopedic care...
Enovis to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024
February 07, 2024 16:15 ET
|
Enovis Corporation
Wilmington, DE, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that Brady Shirley, President and COO,...
Enovis Showcases New Foot & Ankle Offerings at the ACFAS Annual Meeting
January 29, 2024 08:00 ET
|
Enovis Corporation
WILMINGTON, DE, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Today, Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology company, announced it will showcase the latest technologies from...
Enovis to Host Fourth Quarter and Full Year 2023 Conference Call on February 22nd
January 26, 2024 06:00 ET
|
Enovis Corporation
Wilmington, DE, Jan. 26, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call...
Enovis Introduces the DonJoy ROAM™ OA Knee Brace
January 25, 2024 08:30 ET
|
Enovis Corporation
WILMINGTON, DE, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (“Enovis” or the “Company”) (NYSE: ENOV), an innovation-driven medical technology growth company, announced today that its DJO,...
Enovis 完成对 LimaCorporate S.p.A 的收购
January 03, 2024 13:26 ET
|
Enovis Corporation
威尔明顿,特拉华州, Jan. 04, 2024 (GLOBE NEWSWIRE) -- 创新驱动的医疗技术成长型公司 Enovis™ Corporation(NYSE: ENOV,简称“Enovis”或“公司”)今日宣布完成对 LimaCorporate S.p.A (简称“Lima”)的收购。Lima 是私人控股的全球骨科领导者,专注于通过创新的植入物解决方案组合恢复运动。 Lima...
Enovis 完成對 LimaCorporate S.p.A 的收購
January 03, 2024 13:26 ET
|
Enovis Corporation
威爾明頓,特拉華州, Jan. 04, 2024 (GLOBE NEWSWIRE) -- 創新驅動的醫療技術成長型公司 Enovis™ Corporation (NYSE: ENOV,以下簡稱「Enovis」或「公司」)今日宣布已完成對 LimaCorporate S.p.A (以下簡稱「Lima」)的收購。Lima...
Enovis finalise l’acquisition de LimaCorporate S.p.A.
January 03, 2024 13:26 ET
|
Enovis Corporation
WILMINGTON, Delaware, 03 janv. 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE : ENOV, « Enovis » ou la « société ») une entreprise en pleine croissance dans le domaine des technologies médicales...
Enovis schließt Übernahme von LimaCorporate S.p.A. ab
January 03, 2024 13:26 ET
|
Enovis Corporation
WILMINGTON, Delaware, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Die Enovis™ Corporation (NYSE: ENOV, „Enovis“ oder das „Unternehmen“), ein innovationsorientiertes Wachstumsunternehmen im Bereich der...